The correct answer is     (A.) Dyadic International

The company, which has already licensed out some of its energy-related technology, also recently won U.S. Food and Drug Administration approval for an enzyme that can be used in the production of beer and wine. Its shares have gained +145.7% in just four short months. Earlier investors have done even better--the stock's $0.49 nadir this summer has produced a +400% pop for some.

It just goes to show that a stock can indeed continue rising, even after a strong gain. Although the gains might not continue indefinitely, it's no stretch to see such a dramatic trend last for years. Hundreds of stocks have conclusively proven that selling to collect a short-term gain can be ill-advised -- and very costly.

Take Apple (Nasdaq: AAPL), for instance. Had an investor bought shares in late September 2003 for $10.35, he or she could have taken a nice +80% gain the following year when the price hit $18.60. But any investor who did so would have failed to cash in on Apple's eventual rise to today's price of $196.35, a +1,816% gain. Which one would you rather have?

The fact is that short-sighted analysts are the only ones who care about today's results. Investors looking for long-term gains need a more thorough analysis--the kind StreetAuthority editor Andy Obermueller provides in his Government-Driven Investing newsletter. Each month, Andy highlights and provides in-depth analysis of companies poised to capitalize on government activity around the world. It's just one way StreetAuthority helps investors spot stocks that lead to long-term wealth. To learn the names of Andy's other picks, and to learn more about Government-Driven Investing, please visit this link.